Prenetics Global Limited

NASDAQ: PRE · Real-Time Price · USD
5.21
-0.10 (-1.97%)
At close: May 05, 2025, 3:31 PM
5.40
3.65%
After-hours: May 05, 2025, 04:00 PM EDT
-1.97%
Bid 4.75
Market Cap 66.13M
Revenue (ttm) 30.62M
Net Income (ttm) -46.3M
EPS (ttm) -3.71
PE Ratio (ttm) -1.4
Forward PE -7.49
Analyst Buy
Ask 5.55
Volume 11,546
Avg. Volume (20D) 8,821
Open 5.30
Previous Close 5.31
Day's Range 5.19 - 5.40
52-Week Range 3.10 - 6.99
Beta -0.26

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 72.74% from the latest price.

Stock Forecasts
6 months ago
+19.13%
Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription
8 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.